Randomized Controlled Trial of Metacognitive Training: a Clinical Psychological Investigation

Randomized Controlled Trial of Metacognitive Training: a Clinical Psychological Investigation - Randomized Controlled Trial of Metacognitive Training: a Clinical Psychological Investigation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027301

Enrollment

Registered

2017-05-15

Start date

2017-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia

Interventions

Intervention group 1. MCT is practiced with the manual. 2. Subjects participate in ten modules of MCT in one hour group session a week. 3. The ten modules contain eight modules of Cycle A or B, and

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: people (1)diagnosed with schizophrenia(ICD-10) by psychiatrist (2)correspond to "psychotic disorder" in M.I.N.I. (3)allowed to take part in this research by psychiatrist (4)score above 2 in "delusion" of PANSS

Exclusion criteria

Exclusion criteria: people (1)with intellectual disorder, developmental disorder, organic brain dysfunction and substance abuse (2)score above 5 in "hostility", or above 6 "suspicion" of PANSS

Design outcomes

Primary

Measure	Time frame
The scores of positive symptoms in PANSS (1)Pre MCT (2)Five weeks after the beginning of MCT (3)Post MCT (4)Four weeks follow-up	—

Secondary

Measure	Time frame
Global Assessment of Functioning(GAF), Cognitive Bias Questionnaire for psychosis(CBQp), Beck Cognitive Insight Scale(BCIS), Self-Efficacy for Community Life Scale of Schizophrenia(SECL), Maladaptive and Adaptive Coping Styles Questionnaire(MAX), EQ-5D-5L, Beck Depression Inventory 2(BDI-2), Rosenberg Self-esteem Scale(RSES) (1)Pre MCT (2)Five weeks after the beginning of MCT (3)Post MCT (4)Four weeks follow-up	—

Measure

Time frame

Global Assessment of Functioning(GAF), Cognitive Bias Questionnaire for psychosis(CBQp), Beck Cognitive Insight Scale(BCIS), Self-Efficacy for Community Life Scale of Schizophrenia(SECL), Maladaptive and Adaptive Coping Styles Questionnaire(MAX), EQ-5D-5L, Beck Depression Inventory 2(BDI-2), Rosenberg Self-esteem Scale(RSES) (1)Pre MCT (2)Five weeks after the beginning of MCT (3)Post MCT (4)Four weeks follow-up

—

Countries

Japan

Contacts

Public ContactTakuma Ishigaki

The University of Tokyo Graduate School of Arts and Sciences

cisigaki@mail.ecc.u-tokyo.ac.jp03-5454-4438

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026